Synopsis:
Kwality Pharmaceuticals Limited, a Pharma Stock, reports 23.35% YoY revenue growth and a 67.10% YoY net profit surge in Q2 FY26 results.
This Pharma Stock, engaged in the manufacture and export of complex pharmaceutical molecules and finished formulations, including generics, cephalosporins, beta-lactams, oncology, and biologics, jumped 15 percent after the company reported September quarterly results with a 67.10 percent YoY increase in net profit.
With a market capitalization of Rs. 1,021.48 crores, the share of Kwality Pharmaceuticals Limited has reached an intraday high of Rs. 1010.45 per equity share, rising nearly 14.67 percent from its previous day’s close price of Rs. 881.15. Since then, the stock has retreated and is currently trading at Rs. 984.45 per equity share.
Q2 FY26 Result Walkthrough
Coming into the quarterly results of Kwality Pharmaceuticals Limited, the company’s consolidated revenue from operations increased by 23.35 percent YOY, from Rs. 90.03 crore in Q2 FY25 to Rs. 111.05 crore in Q2 FY26, and decreased slightly by 0.39 percent QoQ from Rs. 111.48 crore in Q1 FY26.
In Q2 FY26, Kwality Pharmaceuticals Limited’s consolidated net profit increased by 67.10 percent YOY, reaching Rs. 14.12 crore compared to Rs. 8.45 crore during the same period last year. As compared to Q1 FY26, the net profit has increased by 18.56 percent, from Rs. 11.91 crore. The basic earnings per share increased by 66.87 percent and stood at Rs. 13.60 as against Rs. 8.15 recorded in the same quarter in the previous year, FY2025. Kwality Pharmaceuticals Limited’s revenue and net profit have grown at a CAGR of 21.63 percent and 37.97 percent, respectively, over the last five years.
In terms of return ratios, the company’s ROCE and ROE stand at 18.4 percent and 16.3 percent, respectively. Kwality Pharmaceuticals Limited has an earnings per share (EPS) of Rs. 41.8, and its debt-to-equity ratio is 0.43x.
Company Overview
Kwality Pharmaceuticals Limited was established in 1983 and is headquartered in Amritsar, India. The company is a prominent pharmaceutical company specializing in the manufacturing of complex molecules and finished formulations. The company is known for its advanced manufacturing facilities and strong commitment to research and development.
Kwality Pharma is engaged in producing a broad range of pharmaceutical products, including generics, cephalosporins, beta-lactams, oncology drugs, and niche biologics. It holds multiple global certifications such as WHO-GMP, EU-GMP, and PIC/S, reflecting its compliance with international quality standards.
The company serves markets across Europe, Latin America, Africa, the Middle East, and Asia. The company’s product portfolio includes over 3000 formulations across more than 25 therapeutic areas.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
